Our Core Belief: Bridging the Gap Between Research and Practice
There is a crippling disconnect in our nation’s healthcare system between basic research and utilizing this research in order to better diagnose and treat complex chronic diseases.
The pharmaceutical industry primarily focuses on developing new drugs that use unique New Molecular Entities (NME). Yet, numerous medicinal compounds already proven safe and efficacious are not being combined or used in new ways and tested in clinical trials. ASSIST supports clinical trials to translate well-researched and documented drugs and compounds for new applications to treat complex chronic disease.